Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Mahidol University's Institutional Repository (Mahidol IR)
Simple jQuery Dropdowns
About Us
Ethics
Service
Statistics & Reports
Feedback
Browsing by Author Gabriel Etienne
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 4 of 4
Issue Date
Title
Author(s)
1-Jul-2021
Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis (Leukemia, (2021), 35, 2, (440-453), 10.1038/s41375-020-01111-2)
Hagop M. Kantarjian
;
Timothy P. Hughes
;
Richard A. Larson
;
Dong Wook Kim
;
Surapol Issaragrisil
;
Philipp le Coutre
;
Gabriel Etienne
;
Carla Boquimpani
;
Ricardo Pasquini
;
Richard E. Clark
;
Viviane Dubruille
;
Ian W. Flinn
;
Slawomira Kyrcz-Krzemien
;
Ewa Medras
;
Maria Zanichelli
;
Israel Bendit
;
Silvia Cacciatore
;
Ksenia Titorenko
;
Paola Aimone
;
Giuseppe Saglio
;
Andreas Hochhaus
;
Siriraj Hospital
;
South Australian Health and Medical Research Institute
;
Section of Hematology Oncology, The University of Chicago
;
CHU de Nantes
;
Slaski Uniwersytet Medyczny w Katowicach
;
Charité – Universitätsmedizin Berlin
;
Royal Liverpool University Hospital
;
Universitätsklinikum Jena und Medizinische Fakultät
;
Sarah Cannon Research Institute
;
Universidade Federal do Parana
;
University of Texas MD Anderson Cancer Center
;
Università degli Studi di Torino
;
Novartis International AG
;
The University of Adelaide
;
Universidade de São Paulo
;
Wroclaw Medical University
;
Institut Bergonie
;
The Catholic University of Korea, College of Medicine
;
Novartis Pharma LLC
;
Oncoclínica Rio de Janeiro
;
Hemorio
1-Feb-2021
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Hagop M. Kantarjian
;
Timothy P. Hughes
;
Richard A. Larson
;
Dong Wook Kim
;
Surapol Issaragrisil
;
Philipp le Coutre
;
Gabriel Etienne
;
Carla Boquimpani
;
Ricardo Pasquini
;
Richard E. Clark
;
Viviane Dubruille
;
Ian W. Flinn
;
Slawomira Kyrcz-Krzemien
;
Ewa Medras
;
Maria Zanichelli
;
Israel Bendit
;
Silvia Cacciatore
;
Ksenia Titorenko
;
Paola Aimone
;
Giuseppe Saglio
;
Andreas Hochhaus
;
Siriraj Hospital
;
South Australian Health and Medical Research Institute
;
Section of Hematology Oncology, The University of Chicago
;
CHU de Nantes
;
Slaski Uniwersytet Medyczny w Katowicach
;
Charité – Universitätsmedizin Berlin
;
Royal Liverpool University Hospital
;
Universitätsklinikum Jena und Medizinische Fakultät
;
Sarah Cannon Research Institute
;
Universidade Federal do Parana
;
University of Texas MD Anderson Cancer Center
;
Università degli Studi di Torino
;
Novartis International AG
;
The University of Adelaide
;
Universidade de São Paulo
;
Wroclaw Medical University
;
Institut Bergonie
;
The Catholic University of Korea, College of Medicine
;
Novartis Pharma LLC
;
Oncoclínica Rio de Janeiro
;
Hemorio
17-Jun-2010
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
Giuseppe Saglio
;
Dong Wook Kim
;
Surapol Issaragrisil
;
Philipp Le Coutre
;
Gabriel Etienne
;
Clarisse Lobo
;
Ricardo Pasquini
;
Richard E. Clark
;
Andreas Hochhaus
;
Timothy P. Hughes
;
Neil Gallagher
;
Albert Hoenekopp
;
Mei Dong
;
Ariful Haque
;
Richard A. Larson
;
Hagop M. Kantarjian
;
Universita degli Studi di Torino
;
The Catholic University of Korea
;
Mahidol University
;
Charité – Universitätsmedizin Berlin
;
Institut Bergonie
;
Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti
;
Universidade Federal do Parana
;
Royal Liverpool and Broadgreen University Hospitals NHS Trust
;
Universitatsklinikum Jena und Medizinische Fakultat
;
Royal Adelaide Hospital
;
Novartis International AG
;
Novartis Pharmaceuticals
;
University of Chicago
;
University of Texas MD Anderson Cancer Center
15-May-2017
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study
Philippe Rousselot
;
Stéphane Prost
;
Joelle Guilhot
;
Lydia Roy
;
Gabriel Etienne
;
Laurence Legros
;
Aude Charbonnier
;
Valérie Coiteux
;
Pascale Cony-Makhoul
;
Francoise Huguet
;
Emilie Cayssials
;
Jean Michel Cayuela
;
Francis Relouzat
;
Marc Delord
;
Heriberto Bruzzoni-Giovanelli
;
Laure Morisset
;
François Xavier Mahon
;
François Guilhot
;
Philippe Leboulch
;
Universite de Versailles Saint-Quentin-en-Yvelines
;
CEA Fontenay aux Roses
;
Centre Hospitalier Universitaire de Poitiers
;
Hôpital Henri Mondor
;
Institut Bergonie
;
Centre Hospitalier Universitaire de Nice
;
Institut Paoli-Calmettes
;
Centre Hospitalier Regional Universitaire de Lille
;
Centre Hospitalier Annecy Genevois
;
Institut Universitaire du Cancer
;
Hôpital Saint-Louis
;
Universite Paris 7- Denis Diderot
;
CHV Centre Hospitalier de Versailles
;
Hopital Haut-Lévêque C.H.U de Bordeaux
;
Brigham and Women's Hospital and Harvard Medical School
;
Mahidol University